Kamla Pathak
Pathak, Kamla
VIAF ID: 305728414 (Personal)
Permalink: http://viaf.org/viaf/305728414
Preferred Forms
- 100 0 _ ‡a Kamla Pathak
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Adverse drug reactions and safety considerations of NSAIDs: clinical analysis. | |
Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan. | |
Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system | |
Bifunctional capsular dosage form: novel fanicular cylindrical gastroretentive system of clarithromycin and immediate release granules of ranitidine HCl for simultaneous delivery | |
Buccoadhesive gels of glibenclamide: a means for achieving enhanced bioavailability. | |
Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation. | |
Cavamax W7 composite psoralen ethosomal gel versus cavamax W7 psoralen solid complex gel for topical delivery: A comparative evaluation | |
Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. | |
Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing | |
Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability | |
Development and evaluation of dual controlled release microballoons containing riboflavin and citric acid: in vitro and in vivo evaluation | |
Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study | |
Development of extended release coevaporates and coprecipitates of promethazine HCl with acrylic polymers: formulation considerations. | |
Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis. | |
Dual controlled release, in situ gelling periodontal sol of metronidazole benzoate and serratiopeptidase: statistical optimization and mechanistic evaluation | |
Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes | |
Egg shell membrane as a substrate for optimizing in vitro transbuccal delivery of glipizide. | |
The expanding role of IL-7 and thymic stromal lymphopoietin as therapeutic target for rheumatoid arthritis. | |
Exploiting microspheres as a therapeutic proficient doer for colon delivery: a review. | |
Fast-dissolving ocular films of riboflavin acetate conjugate for treatment of keratoconus in UVA-CXL procedure: ex vivo permeation, hemolytic toxicity and apoptosis detection | |
Floating microspheres: to prolong the gastric retention time in stomach. | |
Formulation and evaluation of oil entrapped gastroretentive floating gel beads of loratadine | |
Formulation and in vitro evaluation of prolonged release floating microspheres of atenolol using multicompartment dissolution apparatus | |
Gastroretentive bilayer film for sustained release of atorvastatin calcium and immediate release of amlodipine besylate: pharmaceutical, pharmacokinetic evaluation, and IVIVC | |
Glyceryl monooleate-coated bioadhesive hollow microspheres of riboflavin for improved gastroretentivity: optimization and pharmacokinetics | |
High-efficiency loading and controlled release of highly water-soluble drug, pravastatin sodium by use of cross-linked β-cyclodextrin. | |
Hydrogen bond replacement--unearthing a novel molecular mechanism of surface solid dispersion for enhanced solubility of a drug for veterinary use. | |
In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug | |
Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets. | |
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders | |
Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography | |
Lipoidal soft hybrid biocarriers in pharmacotherapeutics. | |
Marine bioadhesives: opportunities and challenges | |
Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin. | |
Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting | |
Nanocarrier-based approaches to combat chronic obstructive pulmonary disease | |
Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. | |
Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake | |
Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokinetics. | |
Naproxen glycine conjugate-synthesis, pharmaceutical preformulation and pharmacodynamic evaluation | |
Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment | |
Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin. | |
Optimization studies on development and evaluation of papain-basedin situgelling system for chemomechanical caries removal | |
Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine | |
Optimized prodrug approach: a means for achieving enhanced anti-inflammatory potential in experimentally induced colitis. | |
Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach | |
Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies | |
Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility. | |
Passage-delaying microbeads for controlled delivery of loratadine. | |
Pharmaceutical evaluation and dynamic vapor sorption studies of fast dissolving intraoral films of Loratadine | |
Physicochemical characterization and dissolution enhancement of aceclofenac-hydroxypropyl beta-cyclodextrin binary systems | |
Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation | |
Porous carriers for controlled/modulated drug delivery. | |
Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins. | |
Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery | |
Preparation, Characterization and Pharmacodynamic Evaluation of Fused Dispersions of Simvastatin using PEO-PPO Block Copolymer | |
Product development studies of amino acid conjugate of Aceclofenac | |
Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form. | |
Solid dispersion of meloxicam : factorially designed dosage from for geriatric population | |
Solubility-modulated asymmetric membrane tablets of triprolidine hydrochloride: statistical optimization and evaluation. | |
Statins therapy: a review on conventional and novel formulation approaches. | |
Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas | |
Therapeutic and cosmeceutical potential of ethosomes: An overview. | |
Therapeutic potential of mucoadhesive drug delivery systems--an updated patent review | |
Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery. | |
Thermosensitive periodontal sol of ciprofloxacin hydrochloride and serratiopeptidase: Pharmaceutical and mechanical analysis | |
Topical antiinflammatory effects of Euphorbia prostrata on carrageenan-induced footpad oedema in mice | |
Translabial drug delivery: potential and possibilities | |
Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. | |
Use of solubility parameter to design dry suspension of cefaclor as a dual pack system. | |
Utilizing guar gum for development of "tabs in cap' system of losartan potassium for chronotherapeutics. | |
Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug |